238 related articles for article (PubMed ID: 38277205)
21. Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS/TP53 mutation status and tumor-sideness in colorectal cancers.
Liu X; Xu X; Wu Z; Shan Q; Wang Z; Wu Z; Ding X; Huang W; Wang Z
Front Immunol; 2022; 13():961350. PubMed ID: 36172359
[TBL] [Abstract][Full Text] [Related]
22. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
24. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
Front Immunol; 2021; 12():647209. PubMed ID: 33841428
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.
Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY
BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848
[TBL] [Abstract][Full Text] [Related]
26. The tumor microenvironment in esophageal cancer.
Lin EW; Karakasheva TA; Hicks PD; Bass AJ; Rustgi AK
Oncogene; 2016 Oct; 35(41):5337-5349. PubMed ID: 26923327
[TBL] [Abstract][Full Text] [Related]
27. Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis.
Li C; Guan R; Li W; Wei D; Cao S; Xu C; Chang F; Wang P; Chen L; Lei D
Front Immunol; 2023; 14():1168191. PubMed ID: 37503341
[TBL] [Abstract][Full Text] [Related]
28. Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.
An PG; Wu WJ; Tang YF; Zhang J
Funct Integr Genomics; 2023 May; 23(2):155. PubMed ID: 37162576
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
[TBL] [Abstract][Full Text] [Related]
30. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
Front Immunol; 2021; 12():768115. PubMed ID: 34966389
[TBL] [Abstract][Full Text] [Related]
31. Spatial analysis of stromal signatures identifies invasive front carcinoma-associated fibroblasts as suppressors of anti-tumor immune response in esophageal cancer.
He JZ; Chen Y; Zeng FM; Huang QF; Zhang HF; Wang SH; Yu SX; Pang XX; Liu Y; Xu XE; Wu JY; Shen WJ; Li ZY; Li EM; Xu LY
J Exp Clin Cancer Res; 2023 May; 42(1):136. PubMed ID: 37254126
[TBL] [Abstract][Full Text] [Related]
32. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma.
Chen Z; Zhao M; Liang J; Hu Z; Huang Y; Li M; Pang Y; Lu T; Sui Q; Zhan C; Lin M; Guo W; Wang Q; Tan L
EBioMedicine; 2021 Jul; 69():103459. PubMed ID: 34192657
[TBL] [Abstract][Full Text] [Related]
34. A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression.
Khazaei S; Nouraee N; Moradi A; Mowla SJ
Clin Transl Oncol; 2017 May; 19(5):633-640. PubMed ID: 27896643
[TBL] [Abstract][Full Text] [Related]
35. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
36. Integrating scRNA-seq and bulk RNA-seq to characterize infiltrating cells in the colorectal cancer tumor microenvironment and construct molecular risk models.
Wang Q; Zhang YF; Li CL; Wang Y; Wu L; Wang XR; Huang T; Liu GL; Chen X; Yu Q; He PF
Aging (Albany NY); 2023 Dec; 15(23):13799-13821. PubMed ID: 38054820
[TBL] [Abstract][Full Text] [Related]
37. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
[TBL] [Abstract][Full Text] [Related]
38. Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma.
Guo W; Zhou B; Yang Z; Liu X; Huai Q; Guo L; Xue X; Tan F; Li Y; Xue Q; Gao S; He J
EBioMedicine; 2022 Oct; 84():104281. PubMed ID: 36162205
[TBL] [Abstract][Full Text] [Related]
39. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis.
Zhang X; Peng L; Luo Y; Zhang S; Pu Y; Chen Y; Guo W; Yao J; Shao M; Fan W; Cui Q; Xi Y; Sun Y; Niu X; Zhao X; Chen L; Wang Y; Liu Y; Yang X; Wang C; Zhong C; Tan W; Wang J; Wu C; Lin D
Nat Commun; 2021 Sep; 12(1):5291. PubMed ID: 34489433
[TBL] [Abstract][Full Text] [Related]
40. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
